2013
DOI: 10.1007/s11060-013-1238-8
|View full text |Cite
|
Sign up to set email alerts
|

Optimization of the route of platinum drugs administration to optimize the concomitant treatment with radiotherapy for glioblastoma implanted in the Fischer rat brain

Abstract: Treatment of glioblastoma with platinum compounds modestly improves progression-free survival and may cause toxic effects which prevent use at higher dose that would otherwise improve the antineoplastic effect. To reduce toxicity, we propose to encapsulate the platinum drug in a liposome. We have also tested three methods of drug administration (intra-venous, intra-arterial and intra-arterial combined with blood brain barrier disruption) to determine which one optimizes the tumor cell uptake, limits the toxici… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
42
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
6
1
1

Relationship

1
7

Authors

Journals

citations
Cited by 45 publications
(44 citation statements)
references
References 29 publications
0
42
0
Order By: Relevance
“…The Gamma Knife was chosen because of its high precision to irradiate tumors implanted in rats. Only a single dose of radiation was delivered to rats with the Gamma Knife because it is easier to evaluate the concomitant effect of chemotherapy and radiation with a single dose as well as to compare our previous results [29,30] with those reported in the present study.…”
Section: Radiotherapy With Gamma Knifementioning
confidence: 64%
See 1 more Smart Citation
“…The Gamma Knife was chosen because of its high precision to irradiate tumors implanted in rats. Only a single dose of radiation was delivered to rats with the Gamma Knife because it is easier to evaluate the concomitant effect of chemotherapy and radiation with a single dose as well as to compare our previous results [29,30] with those reported in the present study.…”
Section: Radiotherapy With Gamma Knifementioning
confidence: 64%
“…in the same GBM model, as part of another study by our group (Table 5, Fig. S2) [29]. A MeST of 17 days was measured in the group treated with cisplatin injected i.v., whereas it was only 13 days when an i.a.…”
Section: Discussionmentioning
confidence: 99%
“…2011; Charest et al. 2013). Potential consequences of peripheral neurotoxicity include interference of ion channel function and disruption of primary afferent metabolism, which, upon repeated exposure to oxaliplatin, could lead to persistent axonal degeneration and eventually cell death (Jaggi and Singh 2012; Han and Smith 2013).…”
Section: Discussionmentioning
confidence: 99%
“…Some formulations demonstrated their ability to improve activity of anticancer drugs in vivo, such as topotecan, 220 irinotecan, 214,230,235,259 arsenic trioxide, 255 cisplatin, 237,240,268 and oxaliplatin, 237 and codelivery of synergistic two-drug combinations 257 …”
Section: Design Of Liposomal Drug-delivery Systems For Glioma Therapymentioning
confidence: 99%